Literature DB >> 21596025

Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors.

Anshul Pandya1, Jerrel L Yakel.   

Abstract

Nicotinic acetylcholine receptors are ligand-gated ion conducting transmembrane channels from the Cys-loop receptor super-family. The α4β2 subtype is the predominant heteromeric subtype of nicotinic receptors found in the brain. Allosteric modulators for α4β2 receptors interact at a site other than the orthosteric site where acetylcholine binds. Many compounds which act as allosteric modulators of the α4β2 receptors have been identified, with both positive and negative effects. Such allosteric modulators either increase or decrease the response induced by agonist on the α4β2 receptors. Here we discuss the concept of allosterism as it pertains to the α4β2 receptors and summarize the important features of allosteric modulators for this nicotinic receptor subtype. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596025      PMCID: PMC3162104          DOI: 10.1016/j.bcp.2011.04.020

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  71 in total

1.  Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptors.

Authors:  Brandon J Henderson; Ryan E Pavlovicz; Jerad D Allen; Tatiana F González-Cestari; Crina M Orac; Andrew B Bonnell; Michael X Zhu; R Thomas Boyd; Chenglong Li; Stephen C Bergmeier; Dennis B McKay
Journal:  J Pharmacol Exp Ther       Date:  2010-06-15       Impact factor: 4.030

Review 2.  Positive and negative modulation of nicotinic receptors.

Authors:  Hugo R Arias
Journal:  Adv Protein Chem Struct Biol       Date:  2010       Impact factor: 3.507

Review 3.  Gating of nicotinic ACh receptors: latest insights into ligand binding and function.

Authors:  Jerrel L Yakel
Journal:  J Physiol       Date:  2009-11-16       Impact factor: 5.182

4.  Allosteric modulator Desformylflustrabromine relieves the inhibition of α2β2 and α4β2 nicotinic acetylcholine receptors by β-amyloid(1-42) peptide.

Authors:  Anshul Pandya; Jerrel L Yakel
Journal:  J Mol Neurosci       Date:  2011-03-22       Impact factor: 3.444

5.  A portable site: a binding element for 17β-estradiol can be placed on any subunit of a nicotinic α4β2 receptor.

Authors:  Xiaochun Jin; Joe Henry Steinbach
Journal:  J Neurosci       Date:  2011-03-30       Impact factor: 6.167

6.  Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with alpha4beta2 neuronal nicotinic acetylcholine receptor orthosteric ligands.

Authors:  Maegan M Weltzin; Marvin K Schulte
Journal:  J Pharmacol Exp Ther       Date:  2010-06-01       Impact factor: 4.030

7.  In vitro inhibition of recombinant ligand-gated ion channels by high concentrations of milnacipran.

Authors:  Kazuyoshi Ueta; Takahiro Suzuki; Ichiro Uchida; Takashi Mashimo
Journal:  Psychopharmacology (Berl)       Date:  2004-03-02       Impact factor: 4.530

8.  Structural model for the binding sites of allosterically potentiating ligands on nicotinic acetylcholine receptors.

Authors:  Edgar Luttmann; Jürgen Ludwig; Anja Höffle-Maas; Marek Samochocki; Alfred Maelicke; Gregor Fels
Journal:  ChemMedChem       Date:  2009-11       Impact factor: 3.466

9.  Rat nicotinic acetylcholine receptor alpha2beta2 channels: comparison of functional properties with alpha4beta2 channels in Xenopus oocytes.

Authors:  S S Khiroug; L Khiroug; J L Yakel
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Molecular analysis of nicotinic receptor expression in autism.

Authors:  C M Martin-Ruiz; M Lee; R H Perry; M Baumann; J A Court; E K Perry
Journal:  Brain Res Mol Brain Res       Date:  2004-04-07
View more
  21 in total

1.  Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study.

Authors:  Rebecca L Ashare; Riju Ray; Caryn Lerman; Andrew A Strasser
Journal:  Drug Alcohol Depend       Date:  2012-05-15       Impact factor: 4.492

Review 2.  Nicotinic ACh receptors as therapeutic targets in CNS disorders.

Authors:  Kelly T Dineley; Anshul A Pandya; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2015-01-29       Impact factor: 14.819

3.  NMR structures of the transmembrane domains of the α4β2 nAChR.

Authors:  Vasyl Bondarenko; David Mowrey; Tommy Tillman; Tanxing Cui; Lu Tian Liu; Yan Xu; Pei Tang
Journal:  Biochim Biophys Acta       Date:  2012-02-14

4.  Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors.

Authors:  M Grupe; A A Jensen; P K Ahring; J K Christensen; M Grunnet
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

5.  Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.

Authors:  Jeppe A Olsen; Philip K Ahring; Jette S Kastrup; Michael Gajhede; Thomas Balle
Journal:  J Biol Chem       Date:  2014-06-30       Impact factor: 5.157

6.  Menthol Enhances the Desensitization of Human α3β4 Nicotinic Acetylcholine Receptors.

Authors:  Hoai T Ton; Amanda E Smart; Brittany L Aguilar; Thao T Olson; Kenneth J Kellar; Gerard P Ahern
Journal:  Mol Pharmacol       Date:  2015-05-11       Impact factor: 4.436

7.  Levamisole: A Positive Allosteric Modulator for the α3β4 Nicotinic Acetylcholine Receptors Prevents Weight Gain in the CD-1 Mice on a High Fat Diet.

Authors:  Jeanne A Lewis; Jerrel L Yakel; Anshul A Pandya
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

8.  Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.

Authors:  Anshul A Pandya; Jerrel L Yakel
Journal:  Neuropharmacology       Date:  2013-01-12       Impact factor: 5.250

9.  Effect of triazine derivatives on neuronal nicotinic receptors.

Authors:  Ana Vázquez-Romero; Manuel Criado; Angel Messeguer; Miquel Vidal-Mosquera; José Mulet; Francisco Sala; Salvador Sala
Journal:  ACS Chem Neurosci       Date:  2014-07-07       Impact factor: 4.418

Review 10.  Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review.

Authors:  MacKenzie R Peltier; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-05       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.